| Filed On | Filing |
|---|---|
| 03 Aug 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously disclosed, on February 24, 2026, the Board appointed Mr. Jackson to serve as the Company’s CEO, effective August 1, 2026. On July 28, 2026, the Board took action to expand Mr. Jackson’s responsibilities and, commensurate wi... |
| 01 May 2026 |
8-K/A: Financial Statements and Exhibits
To the shareholder and the Board of Directors of Avadel Pharmaceuticals plc |
| 20 Sep 2016 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 16 Apr 2015 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 29 Sep 2011 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more |
Loading...
